|This week, the Trump Administration signed off on a partnership with Kodak to begin producing critical pharmaceutical ingredients right here in the United States.|
“America is dangerously dependent on foreign supply chains for all three stages of drug production: starting materials used to manufacture active ingredients, the active ingredients themselves and the finished product in the form of tablets, pills and injectables,” Peter Navarro and Adam Boehler write.
“The Kodak project is a big win for the Defense Production Act, a big win for New York and the nation—and a huge step forward toward US pharmaceutical independence.”
Click here to read more.
Post a Comment